跳至主要内容
临床试验/NCT06049550
NCT06049550尚未招募不适用

The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease

RenJi Hospital0 个研究点目标入组 250 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
250
主要终点
renal failure

研究概览

简要总结

Diabetic kidney disease (DKD) is the leading cause for renal replacement therapy in developed country. DKD is also the primary cause of ESKD among middle-aged and elderly people in China. Renal pathological markers have been proved to have clinical and prognostic value in both non diabetic and diabetic kidney diseases. To discriminate lesions by various degrees of severity, the Working Group of the Renal Pathology Society (RPS) developed a pathologic classification for DKD in 2010. The classification is based on glomerular lesions, with a separate evaluation for interstitial and vascular lesions. In a decade, there were several new characteristics common to DKD, such as the presence of mesangiolysis, glomerular hyalinosis, segmental sclerosis and extracapillary hypercellularity, which have been noted in patients with diabetes and may have prognostic importance. But it is still unclear whether thickening of Bowman's capsule predicts the progression of DKD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old, male or female 2) Patients diagnosed as diabetes kidney disease by renal biopsy

排除标准

  • Patients combined with non diabetes kidney disease; 2) Patients with kidney transplant failure; 3) Patients undergoing zero point puncture for kidney transplantation; 4) less than 5 glomeruli in the renal puncture sample.

结局指标

主要结局

renal failure

时间窗: From the diagnosis of diabetes kidney disease by renal biopsy to December 31, 2022

estimated glomerular filtration rate(eGFR)\<15ml/min/1.73m2, renal replacement treatment or death caused by renal disease

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验